Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Large-Sample Real-World Dynamic Cohort Registry: Observing the Clinical Outcomes of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury

NCT07107932 is registered in ClinicalTrials.gov with Zhuhai Trinomab Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07107932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07107932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Large-Sample Real-World Dynamic Cohort Registry: Observing the Clinical Outcomes of Siltartoxatug Injection for Tetanus Prophylaxis Following Injury
Lead sponsor
Zhuhai Trinomab Pharmaceutical Co., Ltd.
Phase
Observational
Overall status
Recruiting
Start date
July 31, 2025
Completion date
March 30, 2029
Enrollment
10,000 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

tetanus